Nexoplex Bio LLC

03/17/2026 | Press release | Archived content

Gritstone bio is now Nexoplex bio!

After emerging from Chapter 11 bankruptcy, hiring a new management team and a dedicated new team of scientists, Gritstone bio is changing its name to Nexoplex bio. This change is reflective of new energy and focus on the development of our portfolio of bispecific antibodies. Watch for more exciting updates as our team progresses our portfolio of bispecifics to provide treatments for unmet needs in oncology.

Media Contact:
Dan Budwick
1AB Media
[email protected]

Nexoplex Bio LLC published this content on March 17, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 13, 2026 at 10:30 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]